We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Human-Machine Collaboration to Redefine Healthcare Market in 2018

By HospiMedica International staff writers
Posted on 26 Dec 2017
Print article
Image: The gap between AI and humans is expected to be bridged in 2018 through a collaboration of humans and machines (Photo courtesy of Techora).
Image: The gap between AI and humans is expected to be bridged in 2018 through a collaboration of humans and machines (Photo courtesy of Techora).
Human-machine collaboration will bridge the gap between artificial intelligence (AI) and humans in 2018, leaving aside the man versus machine competition. Non-traditional players such as Amazon, Apple, Google, and IBM will start having a tangible impact on the healthcare ecosystem. Competing outside their conventional arena, these organizations are pushing traditional healthcare companies to break their main business model and make healthcare more accessible, affordable, and consumer-centric.

These were some of the expert insights offered at Frost & Sullivan’s (Santa Clara, CA, USA) Growth Innovation Leadership (GIL) briefing titled, "Global Healthcare Market Key Predictions for 2018" held on December 13, 2017. Frost & Sullivan's experts have predicted another year of big disruptions, transformations and innovations as the healthcare industry continues to overhaul outmoded business models. Advances in areas ranging from cancer immunotherapy products to blood testing, as well as the convergence of cutting-edge technology such as AI and blockchain, will help shape the healthcare industry into a much-anticipated, value-based care paradigm.

2018 is expected to be a tipping point for the mainstream adoption of popular digital health tech/solutions (AI, mHealth/wearables, telehealth, Big Data analytics, and robotics) and the transition of noble technologies from research/proof-of-concept to actionable healthcare and clinical applications (blockchain and cancer immunotherapy products). Additionally, cloud-based PaaS/SaaS platforms will become integral to any healthcare data monetization model, and the transition of these technologies from ideation to actionable applications will drive growth opportunities across the world.

Furthermore, data monetization will unleash the power of patient data to achieve better outcomes across the healthcare value chain. The digital transformation of patient monitoring, coupled with data hubs using cell phone networks, will drive health revenue, thereby further reducing hospital inpatient census. There will be increasing awareness about the current inefficiencies in healthcare delivery, such as poor utilization of operating theaters. There will be high demand for optimization of resources, care coordination employing technology-based platforms, and products or services that improve the efficiency of healthcare delivery. Highly capitalized players such as Amazon, Alibaba, and Google will reshape whole segments of healthcare, revolutionizing and simplifying patient experiences and patient empowerment.

"Algorithms have outperformed humans in many cases. In 2018, the work of AI will begin to see fruition particularly in the diagnostic imaging market. Therefore, clinicians will start embracing this technology and use it more freely and easily," said Reenita Das, Partner, and Senior Vice President of Transformational Health at Frost & Sullivan.

"Blockchain technology will move from perceived hype to reality bandwagon demonstrating real value with initial commercial deployments across health insurance claim adjudication and revenue cycle management use cases. The debate will now move onto the topic of adoption, exploring [how] and [where] can blockchain technology be used in the healthcare space," added Kamaljit Behera, Industry Analyst, Visionary Healthcare at Frost & Sullivan.

Related Links:
Frost & Sullivan

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
12-Channel ECG
CM1200B
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Wireless Handheld Ultrasound System
TE Air

Print article

Channels

Critical Care

view channel
Image: The permeable wearable electronics developed for long-term biosignal monitoring (Photo courtesy of CityUHK)

Super Permeable Wearable Electronics Enable Long-Term Biosignal Monitoring

Wearable electronics have become integral to enhancing health and fitness by offering continuous tracking of physiological signals over extended periods. This monitoring is crucial for understanding an... Read more

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.